Indian Furosemide Exporters: Complete Supplier Ranking with Market Share — 333 Manufacturers (2026) — TransData Nexus

Q: Who is the largest furosemide supplier from India?

BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the largest furosemide exporter from India with a 25.2% market share and export value of $17.8M.

Q: How many furosemide suppliers are there in India?

There are 333 active furosemide exporters in India, collectively shipping $70.5M worth of furosemide across 4,657 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top furosemide suppliers from India?

The top 5 furosemide suppliers from India — BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, GRAVITI PHARMACEUTICALS PRIVATE LIMITED, IPCA LABORATORIES LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED, AVET LIFESCIENCES PRIVATE LIMITED — together control 58.0% of total furosemide export value from India.

Suresh Sormare

Furosemide

India Pharmaceutical Trade Intelligence

$70.5M333 Suppliers150 CountriesHS 30049099

ExportsIndia → UNITED STATES60.2%India → CANADA7.3%

ImportsCANADA → India$79.8K GERMANY → India$43.9K

#1 Supplier: BAXTER PHARMACEUTICALS #1 Buyer: BAXTER HEALTHCARE

Furosemide Suppliers from India (2026) — 333 Exporters, $70.5M Market | TransData Nexus | TransData Nexus

Who Exports Furosemide from India — 333 Suppliers Behind a $70.5M Market

India's furosemide export market is supplied by 333 active exporters who collectively shipped $70.5M across 4,657 shipments. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED leads with a 25.2% market share, followed by GRAVITI PHARMACEUTICALS PRIVATE LIMITED and IPCA LABORATORIES LIMITED. The top 5 suppliers together control 58.0% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Furosemide Suppliers & Exporters — 333 manufacturers, $70.5M export market, top destinations and formulations — Furosemide supplier data — 333 exporters · $70.5M market · 4,657 shipmentsTransData Nexus · Indian Customs Data

Top Furosemide Exporters from India — Ranked by Export Value

BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the leading furosemide exporter from India, holding a 25.2% share of the $70.5M market across 4,657 shipments from 333 exporters. The top 5 suppliers — BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, GRAVITI PHARMACEUTICALS PRIVATE LIMITED, IPCA LABORATORIES LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED, AVET LIFESCIENCES PRIVATE LIMITED — collectively control 58.0% of total export value, indicating a moderately concentrated market. Individual shares are: BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED (25.2%), GRAVITI PHARMACEUTICALS PRIVATE LIMITED (20.3%), IPCA LABORATORIES LIMITED (4.8%), PFIZER HEALTHCARE INDIA PRIVATE LIMITED (3.9%), AVET LIFESCIENCES PRIVATE LIMITED (3.8%).

Top Furosemide Exporters from India

Ranked by export value · 333 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Furosemide Exporters from India — Ranked by Export Value. 333 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share

Furosemide — Export Intelligence Video

Visual overview of India's furosemide supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's furosemide pharmaceutical supplier landscape — $70.5M in total trade, 333 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Furosemide exporters

Certification and compliance status for top Furosemide suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Emcure Pharmaceuticals Limited	Warning Letter, August 20	Yes, 2006	Yes	Not verified	Received FDA warning letter in August 2019 for data manipulation violations at H
Lincoln Pharmaceuticals Ltd	Not Listed	Yes, 1984	Yes, May 2020	Not verified	Received EU GMP certification for Khatraj facility in May 2020.
Maiva Pharma Private Limited	Approved	Unknown	Unknown	Multiple	Received FDA approval for multiple products, including Furosemide, as of Februar
Aurobindo Pharma Ltd	Approved	Unknown	Unknown	Not verified	Manufactures generic pharmaceuticals and APIs; markets products in over 125 coun
Alembic Pharmaceuticals Ltd	Approved	Unknown	Unknown	223	Received multiple FDA approvals between 2024 and 2025, increasing cumulative AND
Intas Pharmaceuticals Ltd	Approved	Yes, 2007	Yes	Not verified	Received EU GMP certification in April 2007; operates 22 manufacturing plants gl
Glenmark Pharmaceuticals Ltd	Approved	Unknown	Unknown	Not verified	Headquartered in Mumbai; operates globally in pharmaceuticals and vaccines.
Avet Lifesciences Private Limited	Approved	Unknown	Unknown	Multiple	Received FDA approval for multiple products, including Furosemide, as of Februar

TransData Nexus reviewed the regulatory standing of 8 leading Furosemide exporters from India. 6 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 3 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Furosemide sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and bulk drugs. For instance, A.R. Life Sciences, established in 2007, manufactures a wide range of APIs and intermediates, adhering to Good Manufacturing Practices (GMP) and holding ISO 9001:2015 certification. Additionally, Hy-Gro Chemicals focuses on developing and manufacturing cost-effective APIs and intermediates, emphasizing quality and sustainability.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and biogenerics manufacturing. Vadodara, in particular, is a significant hub for pharmaceutical industries, hosting numerous companies involved in formulations and biogenerics. For example, Ester Formulations, established in 2000, manufactures and exports a comprehensive range of pharmaceutical formulations, including tablets, capsules, oral liquids, suspensions, soft gelatin capsules, and injectables. Additionally, Schwitz Biotech in Ahmedabad formulates, manufactures, and exports a wide range of pharmaceutical formulations, adhering to FDA, WHO, GMP, and ISO 9002 quality standards.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Furosemide exporters from India

May 2023

M&A

Baxter Pharmaceuticals India Private Limited — Baxter divests BioPharma Solutions to Advent and Warburg Pincus

Baxter International Inc. announced a definitive agreement to divest its BioPharma Solutions business to Advent International and Warburg Pincus for $4.25 billion. The transaction is expected to close in the second half of 2023, subject to regulatory approvals. - IMPACT: This divestiture may lead to a strategic realignment of Baxter's operations, potentially affecting its Furosemide export capabilities.

Impact: This divestiture may lead to a strategic realignment of Baxter's operations, potentially affecting its Furosemide export capabilities.

TransData Nexus Industry Research · Regulatory filings and press releases · Mar 2026

Common Questions — Furosemide Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which furosemide supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED leads with 142 recorded shipments worth $17.8M. GRAVITI PHARMACEUTICALS PRIVATE LIMITED (1,728 shipments) and IPCA LABORATORIES LIMITED (72 shipments) are also established high-volume exporters.

Q How many furosemide manufacturers are there in India?

India has 333 active furosemide exporters with a combined export market of $70.5M across 4,657 shipments to 150 countries. The top 5 suppliers hold 58.0% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for furosemide from India?

Average FOB unit price: $1.74 per unit, ranging from $0.00 to $1018.62. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Furosemide

Furosemide

Who Exports Furosemide from India — 333 Suppliers Behind a $70.5M Market

Top Furosemide Exporters from India — Ranked by Export Value

Top Furosemide Exporters from India

Related Analysis

Need Details?

Furosemide — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Baxter Pharmaceuticals India Private Limited — Baxter divests BioPharma Solutions to Advent and Warburg Pincus

Common Questions — Furosemide Suppliers from India

Q Which furosemide supplier from India is the most reliable for bulk orders?

Q How many furosemide manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for furosemide from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Analysis Methodology